Search

Author/Creator Bjerrum, Ole W.

1. A phase II study of vorinostat (MK‐0683) in patients with polycythaemia vera and essential thrombocythaemia. (11th June 2013)

Authors:
Andersen, Christen L.; McMullin, Mary F.; Ejerblad, Elisabeth; Zweegman, Sonja; Harrison, Claire; Fernandes, Savio; Bareford, David; Knapper, Steven; Samuelsson, Jan; Löfvenberg, Eva; Linder, Olle; Andreasson, Bjørn; Ahlstrand, Erik; Jensen, Morten K.; Bjerrum, Ole W.; Vestergaard, Hanne; Larsen,...
Journal:
British journal of haematology
Issue:
Volume 162:Number 4(2013:Aug.)
Page Start:
498
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Expansion of circulating CD56bright natural killer cells in patients with JAK2‐positive chronic myeloproliferative neoplasms during treatment with interferon‐α. (24th September 2014)

Authors:
Riley, Caroline H.; Hansen, Morten; Brimnes, Marie K.; Hasselbalch, Hans C.; Bjerrum, Ole W.; Straten, Per thor; Svane, Inge Marie; Jensen, Morten Krogh
Journal:
European journal of haematology
Issue:
Volume 94:Number 3(2015:Mar.)
Page Start:
227
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia. (21st March 2019)

Authors:
Ali, Sahra; Dunmore, Helen‐Marie; Karres, Dominik; Hay, Justin L.; Salmonsson, Tomas; Gisselbrecht, Christian; Sarac, Sinan B.; Bjerrum, Ole W.; Hovgaard, Doris; Barbachano, Yolanda; Nagercoil, Nithyanandan; Pignatti, Francesco
Journal:
Oncologist
Issue:
Volume 24:Number 5(2019)
Page Start:
e171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗